Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models

European Journal of Neuroscience

Volumn 37, Issue 12, 2013, Pages 1994-2004

  Thomason, Lynsie A M ^a   Stefanovic, Bojana ^a,b   Mclaurin, Joanne ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canada   (Canada)

Author keywords

Alzheimer disease; Amyloid; Cerebral amyloid angiopathy; Structure function; Vascular factors

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; BETA DYSTROGLYCAN; BETA3 INTEGRIN; BEXAROTENE; COLLAGEN TYPE 4; FIBRIN; FIBRINOGEN; FIBRONECTIN; GLUCOSE TRANSPORTER 1; INOSITOL DERIVATIVE; LAMININ; LOSARTAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10D5; MONOCLONAL ANTIBODY 6E10; SCYLLOINOSITOL; SIMVASTATIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTIINFLAMMATORY ACTIVITY; BIOACCUMULATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHEMOPROPHYLAXIS; COGNITIVE DEFECT; CONTINUOUS INFUSION; DRUG MECHANISM; HUMAN; HYPERCAPNIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC THERAPY; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL HEMORRHAGE; CEREBRUM; DISEASE MODELS, ANIMAL; INOSITOL; MICE; SIMVASTATIN;

EID: 84879201459     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12181     Document Type: Review

References (81)

1. Bard, F., Cannon, C., Barbour, R., Burke, R.L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D. & Yednock, T. (2000) Peripherally administered antibodies against amyloid beta- peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med., 6, 916-919.
2. Bateman, R.J., Xiong, C., Benzinger, T.L.S., Fagan, A.M., Goate, A., Fox, N.C., Marcus, D.S., Cairns, N.J., Xie, X., Blazey, T.M., Holtzman, D.M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P.S., Ghetti, B., Klunk, W.E., McDade, E., Martins, R.N., Masters, C.L., Mayeux, R., Ringman, J.M., Rossor, M.N., Schofield, P.R., Sperling, R.A., Salloway, S., Morris, J.C. & for the Dominantly Inherited Alzheimer Network. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New Engl. J. Med., 367, 795-804.
3. Beckmann, N., Schuler, A., Mueggler, T., Meyer, E.P., Wiederhold, K.-H., Staufenbiel, M. & Krucker, T. (2003) Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J. Neurosci., 23, 8453-8459.
4. Buchhave, P., Minthon, L., Zetterberg, H., Wallin, A.K., Blennow, K. & Hansson, O. (2012) Cerebrospinal fluid levels of β-amyloid 1-42, but not Tau are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiat., 69, 98-106.
5. Calhoun, M.E., Burgermeister, P., Phinney, A.L., Stalder, M.M., Tolnay, M., Wiederhold, K.-H., Abramowski, D., Sturchler-Pierrat, C., Sommer, B., Staufenbiel, M. & Jucker, M. (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA, 96, 14088-14093.
6. Callaway, E. (2012) Alzheimer's drugs take a new tack. Nature, 489, 13-14.
7. Chishti, M.A., Yang, D., Janus, C., Phinney, A.L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., Turner, S., Lozza, G., Grilli, M., Kunicki, S., Morissette, C., Paquette, J., Gervais, F., Bergeron, C., Fraser, P.E., Carlson, G.A., St George-Hyslop, P. & Westaway, D. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem., 276, 21562-21570.
8. Christie, R., Yamada, M., Moskowitz, M. & Hyman, B. (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am. J. Pathol., 158, 1065-1071.
9. Cordonnier, C. & van der Flier, W.M. (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain, 134, 335-344.
10. Cramer, P.E., Cirrito, J.R., Wesson, D.W., Lee, C.Y.D., Karlo, J.C., Zinn, A.E., Casali, B.T., Restivo, J.L., Goebel, W.D., James, M.J., Brunden, K.R., Wilson, D.A. & Landreth, G.E. (2012) ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science, 335, 1503-1506.
11. Dai, W., Lopez, O., Carmichael, O., Becker, J., Kuller, L. & Gach, H. (2009) Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology, 250, 856-866.
12. Danielyan, L., Klein, R., Hanson, L.R., Buadze, M., Schwab, M., Gleiter, C.H. & Frey, W.H. II (2010) Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuv. Res., 13, 195-201.
13. Davis, J., Xu, F., Deane, R., Romanov, G., Previti, M.L., Zeigler, K., Zlokovic, B.V. & Van Nostrand, W.E. (2004) Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor. J. Biol. Chem., 279, 20296-20306.
14. Detre, J. & Alsop, D. (1999) Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur. J. Radiol., 30, 115-124.
15. Dorr, A., Sahota, B., Chinta, L.V., Brown, M.E., Lai, A.Y., Ma, K., Hawkes, C.A., McLaurin, J. & Stefanovic, B. (2012) Amyloid-ß-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain, 135, 3039-3050.
16. Fischer, V.W., Siddiqi, A. & Yusufaly, Y. (1990) Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol., 79, 672-679.
17. Fisher, M., Vasilevko, V., Passos, G.F., Ventura, C., Quiring, D. & Cribbs, D.H. (2011) Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy. Stroke, 42, 3300-3303.
18. Fleisher, A.S., Chen, K., Quiroz, Y.T., Jakimovich, L.J., Gutierrez-Gomez, M., Langoi, C.M., Langbaum, J.B.S., Ayutyanont, N., Roontiva, A., Thiyyagura, P., Lee, W., Mo, H., Lopez, L., Moreno, S., Acosta-Baena, N., Giraldo, M., Garcia, G., Reiman, R.A., Huentelman, M.J., Kosik, K.S., Tariot, P.N., Lopera, F. & Reiman, E.M. (2012) Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross sectional study. Lancet Neurol., 11, 1057-1065.
19. Francis, B.M., Kim, J., Barakat, M.E., Fraenkl, S., Yucel, Y.H., Peng, S., Michalski, B., Fahnestock, M., McLaurin, J. & Mount, H.T.J. (2012) Object recognition memory and BDNF expression are reduced in young TgCRND8 mice. Neurobiol. Aging, 33, 555-563.
20. Girouard, H. & Iadecola, C. (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol., 100, 328-335.
21. Gorelick, P.B., Scuteri, A., Black, S.E., DeCarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D., Petersen, R.C., Schneider, J.A., Tzourio, C., Arnett, D.K., Bennett, D.A., Chui, H.C., Higashida, R.T., Lindquist, R., Nilsson, P.M., Roman, G.C., Sellke, F.W. & Seshadri, S. (2011) Vascular contributions to cognitive impairment and dementia. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42, 2672-2713.
22. Greenberg, S.M. (2002) Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc. Dis., 13(Suppl. 2), 42-47.
23. van Groen, T., Kiliaan, A.J. & Kadish, I. (2006) Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice. Neurobiol. Dis., 23, 653-662.
24. Hajjar, I., Brown, L., Mack, W.J. & Chui, H. (2012) Impact of angiotensin receptor blockers on Alzheimer's disease pathology in a large brain autopsy series. Arch. Neurol., 69, 1632-1638.
25. Han, B.H., Zhou, M.-L., Abousaleh, F., Brendza, R.P., Dietrich, H.H., Koenigsknecht-Talboo, J., Cirrito, J.R., Milner, E., Holtzman, D.M. & Zipfel, G.J. (2008) Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-ß peptide, partial restoration via γ-secretase inhibition. J. Neurosci., 28, 13542-13550.
26. Hawkes, C.A. & McLaurin, J. (2009) Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebralamyloid angiopathy. Proc. Natl. Acad. Sci. USA, 106, 1261-1266.
27. Hawkes, C.A., Härtig, W., Kacza, J., Schliebs, R., Weller, R.O., Nicoll, J.A. & Carare, R.O. (2011) Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol., 121, 431-443.
28. Hayashi, S., Sato, N., Yamamoto, A., Ikegame, Y., Nakashima, S., Ogihara, T. & Morishita, R. (2009) Alzheimer disease-associated peptide, amyloid beta40, inhibits vascular regeneration with induction of endothelial autophagy. Arterioscl. Throm. Vas., 29, 1909-1915.
29. Herzig, M.C., Winkler, D.T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S.D., Danner, S., Abramowski, D., Stürchler-Pierrat, C., Bürki, K., van Duinen, S.G., Maat-Schieman, M.L.C., Staufenbiel, M., Mathews, P.M. & Jucker, M. (2004) Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci., 7, 954-960.
30. Holland, C.M., Smith, E.E., Csapo, I., Gurol, M.E., Brylka, D.A., Killiany, R.J., Blacker, D., Albert, M.S., Guttmann, C.R. & Greenberg, S.M. (2008) Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke, 39, 1127-1133.
31. Honjo, K., Black, S.E. & Verhoeff, N.P. (2012) Alzheimer's disease, cerebrovascular disease, and the β-amyloid cascade. Can. J. Neurol., 39, 712-728.
32. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. & Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 274, 99-102.
33. Huang, Y., Potter, R., Sigurdson, W., Santacruz, A., Shih, S., Ju, Y.-E., Kasten, T., Morris, J.C., Minun, M., Duntley, S. & Bateman, R.J. (2012) Effects of age and amyloid deposition on Ab dynamics in the human central nervous system. Arch. Neurol., 69, 51-58.
34. Hunter, J.M., Kwan, J., Malek-Ahmadi, M., Maarouf, C.L., Kokjohn, T.A., Belden, C., Sabbagh, M.N., Beach, T.G. & Roher, A.E. (2012) Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS ONE, 7, e36893.
35. Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C. & Trojanowski, J.Q. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol., 9, 119-128.
36. Jagust, W.J., Landau, S.M. & for the Alzheimer's Disease Neuroimaging Initiative. (2012) Apolipoprotein E, not fibrillary β-amyloid, reduces cerebral glucose metabolism in normal aging. J. Neurosci., 32, 18227-18233.
37. Johnson, N.A., Jahng, G.H., Weiner, M.W., Miller, B.L., Chui, H.C., Jagust, W.J., Gorno-Tempini, M.L. & Schuff, N. (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology, 234, 851-859.
38. Kalaria, R.N. (1996) Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Therapeut., 72, 193-214.
39. Kalaria, R.N. (2002) Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis., 13(Suppl. 2), 48-52..
40. Kalaria, R.N. (2012) Cerebrovascular disease and mechanisms of cognitive impairment. Evidence from clinicopathological studies in humans. Stroke, 43, 2526-2534.
41. Klohs, J., Deistung, A., Schweser, F., Grandjea, J., Dominietto, M., Waschkies, C., Nitsch, R.M., Knuese, I., Reichenbach, J.R. & Rudin, M. (2011) Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J. Cerebr. Blood F. Met., 31, 2282-2292.
42. Klohs, J., Baltes, C., Princz-Kranz, F., Ratering, D., Nitsch, R.M., Knuesel, I. & Rudin, M. (2012) Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. J. Neurosci., 32, 1705-1713.
43. Knobloch, M., Konietzko, U., Krebs, D.C. & Nitsch, R.M. (2007) Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice. Neurobiol. Aging, 28, 1297-1306.
44. Lee, G.D., Aruna, J.H., Barrett, P.M., Lei, D.L., Ingram, D.K. & Mouton, P.R. (2005) Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Brain Res. Bull., 65, 317-322.
45. Li, N.-C., Lee, A., Whitmer, R.A., Kivipelto, M., Lawler, E., Kazis, L.E. & Wolozin, B. (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ, 340, b5465.
46. McLaurin, J., Golomb, R., Jurewiczi, A., Anteli, J.P. & Fraser, P.E. (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity. J. Biol. Chem., 275, 18495-18502.
47. McLaurin, J., Kierstead, M.E., Brown, M.E., Hawkes, C.A., Lambermon, M.H., Phinney, A.L., Darabie, A.A., Cousins, J.E., French, J.E., Lan, M.F., Chen, F., Wong, S.S., Mount, H.T., Fraser, P.E., Westaway, D. & St George-Hyslop, P. (2006) Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat. Med., 12, 801-808.
48. Merlini, M. & Meyer, E.P. (2011) Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol., 122, 293-311.
49. Miao, J., Feng Xu, F., Davis, J., Otte-Höller, I., Verbeek, M.M. & Van Nostrand, W.E. (2005) Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid β precursor protein. Am. J. Pathol., 167, 505-515.
50. Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel, M. & Rudin, M. (2002) Compromised hemodynamic response in amyloid precursor protein transgenic mice. J. Neurosci., 22, 7218-7224.
51. Niwa, K., Younkin, L., Ebeling, C., Turner, S.K., Westaway, D., Younkin, S., Ashe, K.H., Carlson, G.A. & Iadecola, C. (2000) Aβ1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc. Natl. Acad. Sci. USA, 97, 9735-9740.
52. Niwa, K., Porter, V.A., Kazama, K., Cornfield, D., Carlson, G.A. & Iadecola, C. (2001) Aβ-peptides enhance vasoconstriction in cerebral circulation. Am. J. Physiol.-Heart C., 281, H2417-H2424.
53. Paris, D., Patel, N., DelleDonne, A., Quadros, A., Smeed, R. & Mullan, M. (2004a) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett., 366, 80-85.
54. Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G.A. & Iadecola, C. (2005) NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid β peptide. J. Neurosci., 25, 1769-1777.
55. Park, L., Zhou, P., Pitstick, R., Capone, C., Anrather, J., Norris, E.H., Younkin, L., Younkin, S., Carlson, G., McEwen, B.S. & Iadecola, C. (2008) Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl. Acad. Sci. USA, 105, 1347-1352.
56. Paul, J., Strickland, S. & Melchor, P.J. (2007) Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med., 204, 1999-2008.
57. Perlmutter, L.S. (1994) Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol. Neurobiol., 9, 33-40.
58. Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufenbiel, M., Mathews, P.M. & Jucker, M. (2002) Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science, 298, 1379.
59. Pimentel-Coelho, P.M. & Rivest, S. (2012) The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur. J. Neurosci., 35, 1917-1937.
60. Prada, C.M., Garcia-Alloza, M., Betensky, R.A., Zhang-Nunes, S.X., Greenberg, S.M., Bacskai, B.J. & Frosch, M.P. (2007) Antibody-mediated clearance of amyloid-β peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J. Neurosci., 27, 1973-1980.
61. Princz-Kranz, F.L., Mueggler, T., Knobloch, M., Nitsch, R.M. & Rudin, M. (2010) Vascular response to acetazolamide decreases as a function of age in the arcAβ mouse model of cerebral amyloidosis. Neurobiol. Dis., 40, 284-292.
62. Protas, H.D., Chen, K., Langbaum, J.B.S., Fleisher, A.S., Alexander, G.E., Lee, W., Bandy, D., deLeon, M.J., Mosconi, L., Buckley, S., Truran-Sacrey, D., Schuff, N., Weiner, M.W., Caselli, R.J. & Reiman, E.M. (2012) Posterior cingulated glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal late-middle aged persons at 3 levels of genetic risk for Alzheimer disease. Arch. Neurol., doi:10.1001/2013.jamaneurol.286. [Epub ahead of print].
63. Reiman, E.M., Quiroz, Y.T., Fleisher, A.S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A.M., Shah, A.R., Alvarez, S., Arbelaez, A., Giraldo, M., Acosta-Baena, N., Sperling, R.A., Dickerson, B., Stern, C.E., Tirado, V., Munoz, C., Reiman, R.A., Huentelman, M.J., Alexander, G.E., Langbaum, J.B.S., Kosik, K.S., Tariot, P.N. & Lopera, F. (2012) Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol., 11, 1048-1056.
64. Sadowski, M.J., Pankiewicz, J., Scholtzova, H., Mehta, P.D., Prelli, F., Quartermain, D. & Wisniewski, T. (2006) Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 103, 18787-18792.
65. Schultheiss, C., Blechert, B., Gaertner, F.C., Drecoll, E., Mueller, J., Weber, G.F., Drzezga, A. & Essler, M. (2006) In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease. Angiogenesis, 9, 59-65.
66. Shin, H.K., Jones, P.B., Garcia-Alloza, M., Borrelli, L., Greenberg, S.M., Bacskai, B.J., Frosch, M.P., Hyman, B.T., Moskowitz1, M.A. & Ayata, C. (2007) Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain, 130, 2310-2319.
67. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R., Kaye, J., Montine, T.J., Park, D.C., Reiman, E.M., Rowe, C.C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M.C., Thies, B., Morrison-Bogorad, M., Wagster, M.V. & Phelps, C.H. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute of Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement., 7, 280-292.
68. Suh, Y.-H. & Checler, F. (2002) Amyloid precursor protein, presenilins and a-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev., 54, 469-525.
69. Suo, Z., Humphrey, J., Kundtz, A., Sethi, F., Placzek, A., Crawford, F. & Mullan, M. (1998) Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci. Lett., 257, 77-80.
70. 2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann. NY Acad. Sci., 1097, 40-50.
71. Thakker, D.R., Weatherspoon, M.R., Harrison, J., Keene, T.E., Lane, D.S., Kaemmerer, W.F., Stewart, G.R. & Shafer, L.L. (2009) Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc. Natl. Acad. Sci. USA, 106, 4501-4506.
72. Thal, D.R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S. & Beckmann, N. (2009) Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol. Aging, 30, 1936-1948.
73. Tong, X.-K., Lecrux, C. & Hamel, E. (2012) Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J. Neurosci., 32, 4705-4715.
74. Van Dam, D., D'Hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, F. & De Deyn, P.P. (2003) Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur. J. Neurosci., 17, 388-396.
75. Wang, J., Ho, L., Chen, L., Zhao, Z., Zhao, W., Qian, X., Humala, N., Seror, I., Bartholomew, S., Rosendorff, C. & Pasinetti, G.M. (2007) Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J. Clin. Invest., 117, 3393-3402.
76. Wilcock, D.M., Rojiani, A., Rosenthal, A., Subbarao, S., Freeman, M.J., Gordon, M.N. & Morgan, D. (2004) Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J. Neuroinflamm., 1, 24.
77. Winkler, D.T., Bondolfi, L., Herzig, M.C., Jann, L., Calhoun, M.E., Wiederhold, K.-H., Tolnay, M., Staufenbiel, M. & Jucker, M. (2001) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J. Neurosci., 21, 1619-1627.
78. Xu, F., Grande, A.M., Robinson, J.K., Previti, M.L., Vasek, M., Davis, J. & Van Nostrand, W.E. (2007) Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience, 146, 98-107.
79. Yang, J., Jia, Y., Mehtab, P., Batesa, K.A., Suna, Y. & Wisniewskia, T. (2011) Blocking the Apolipoprotein E/Amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. J. Alzheimers Dis., 24, 269-285.
80. Yoshiura, T., Hiwatashi, A., Yamashita, K., Ohyagi, Y., Monji, A., Takayama, Y., Nagao, E., Kamano, H., Noguchi, T. & Honda, H. (2009) Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. Am. J. Neuroradiol., 30, 1388-1393.
81. Zlokovic, B.V. (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci., 12, 723-738.